CIUSSS de la Mauricie-et-du-Centre-du-Quebec

Trois-Rivières, Quebec G8Z 3R9

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Lung Cancer, Myocardial Infarction, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) — Completed